How many clinical trials are there for Antineoplastics Toxicity?

PlainTrial tracks 1 US clinical trials for Antineoplastics Toxicity, of which 1 are currently recruiting.

Which interventions appear most often on Antineoplastics Toxicity trial records?

Stopping Heart Failure Medication(s) is the most-linked intervention name on Antineoplastics Toxicity records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Antineoplastics Toxicity?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Antineoplastics Toxicity: later-stage trial registry

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Antineoplastics Toxicity trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Antineoplastics Toxicity: 1 US clinical trial tracked, 1 recruiting.

Antineoplastics Toxicity is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University Health Network, Toronto, running 1 of these trials.

Enrollment posture brief

Registry condition antineoplastics-toxicity

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Antineoplastics Toxicity

Antineoplastics Toxicity lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Antineoplastics Toxicity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Antineoplastics Toxicity is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING Phase 4 335 participants

The STOP-MED CTRCD Trial

University Health Network, Toronto

NCT06183437

Phase Distribution

Phase	Trial count
Phase 4	1

Top Sponsors

University Health Network, Toronto 1 trials

Named interventions

Most-linked intervention names on Antineoplastics Toxicity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Stopping Heart Failure Medication(s) Other

1 trials

US sites by state

Facility locations filed on Antineoplastics Toxicity trials. A trial with sites in several states counts in each.

Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Antineoplastics Toxicity page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Antineoplastics Toxicity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
University Health Network, Toronto sponsors the most Antineoplastics Toxicity trials on record, review their full trial history before evaluating a specific study. See University Health Network, Toronto's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Antineoplastics Toxicity condition card totals 1 registered trials; most-linked intervention Stopping Heart Failure Medication(s); top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.